< Back to situations

Get alerts on this situation

We’ll email you as it develops, and you can follow the whole thread from day one.

Unsubscribe anytime.

[SITUATION] · [ACTIVE]

4 clusters · 28 sources · 8 days · First seen 8 days ago · Last updated about 18 hours ago

Categories: HEALTH

AIDS 2026 conference: cuts, stigma & remission cases

Entities: Jeff Graham · International AIDS Conference · Tackle HIV · Rio de Janeiro · CCR5‑Δ32 mutation

Overview

The 26th International AIDS Conference convened in Rio de Janeiro from July 26‑31, drawing more than 20,000 delegates and featuring a free‑access Global Village with hundreds of sessions and daily shuttle service. Activists repeatedly disrupted U.S. Global AIDS Coordinator Jeff Graham’s speeches, denouncing the Trump‑Vance administration’s aid freeze that has shuttered PEPFAR sites, reduced PrEP enrolment and limited condom distribution. In response, U.S. Secretary of State Marco Rubio granted a waiver to keep essential PEPFAR assistance operating during the broader freeze.

A pre‑conference UNAIDS briefing warned of an 18 % global funding shortfall for 2024‑2025, projecting 1.2 million new infections and 570 000 AIDS‑related deaths in 2025, with 22 % of people living with HIV untreated and a possible three‑million‑infection increase by 2030. The briefing highlighted lenacapavir, a long‑acting preventive drug, as clinically effective but priced beyond reach for many low‑income programmes.

Research presented at the conference revealed persistent stigma in Brazil: 36 % of surveyed adults believed heterosexual men, and 37 % believed heterosexual women, were not at risk of HIV; only 48 % had ever been tested, and 19 % thought people living with HIV cannot have a normal sexual life. The authors warned that such attitudes could cause up to 440 000 avoidable deaths this decade. Brazil recorded 39 216 new infections in 2025, met its 95‑95‑95 targets for diagnosis and viral suppression, and is evaluating public‑sector coverage of injectable PrEP.

Scientists also announced two additional cases of HIV remission following hematopoietic stem‑cell transplants from CCR5‑Δ32‑positive donors, raising the worldwide total to 13. The “Kansas City patient” (USA) remains virus‑free after 14 months; the “Essen patient” (Germany) after 12 months, though he experienced a hepatitis B recurrence. Researchers stressed that remission, not cure, requires long‑term monitoring.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

[● 6 SOURCES] Two new cases of HIV remission after hematopoietic stem‑cell transplantation using CCR5‑delta32 donors were reported, bringing the worldwide total of undetectable patients after transplant to 13. (Conference presentation)
[● 6 SOURCES] The 'Kansas City patient' has been HIV‑free for 14 months after transplant, and the 'Essen patient' for 12 months, though hepatitis B recurred in the latter. (Conference presentation)
[● 5 SOURCES] The Tackle HIV survey warned that stigma could cause about 440,000 avoidable deaths this decade. (Tackle HIV research)
[● 5 SOURCES] Brazil reported 39,216 new HIV infections in 2025, with 38.4% of cases located in the Southeast region. (Brazilian Epidemiological Bulletin 2025)
[● 5 SOURCES] Only 48% of surveyed Brazilian adults have ever taken an HIV test. (Tackle HIV survey)
[● 5 SOURCES] 36% of respondents think heterosexual men are not at risk of HIV; 37% think heterosexual women are not at risk. (Tackle HIV survey)
[● 2 SOURCES] Brazil achieved the UNAIDS 95‑95‑95 targets: 95% of people with HIV know their status (2020) and 95% of those in treatment have viral suppression (2024). (Brazilian health authorities)
[○ 1 SOURCE] Brazil's federal government is studying the inclusion of injectable PrEP in the public health system (SUS). (Brazilian government statements)

Timeline

about 18 hours ago

[HEALTH] 17 sources
Rio de Janeiro AIDS Conference Highlights HIV Stigma Study and Stem‑Cell Remission Cases
At Rio's 26th International AIDS Conference, Brazil reported 39,216 HIV cases and a Tackle HIV survey showing widespread stigma that could cause 440,000 avoidable deaths, while scientists announced two new stem
1 day ago

[HEALTH] 3 sources
Rio 2026 AIDS Conference Shows Funding Cuts and Access Gaps for HIV Prevention
Protesters at the Rio 2026 AIDS Conference denounced U.S. aid cuts and highlighted funding declines, while a UNAIDS report warned of rising HIV infections and highlighted the new drug lenacapavir.
6 days ago

[HEALTH] 4 sources
Rio de Janeiro AIDS 2026 Global Village Draws Communities Amid Funding Cuts
The AIDS 2026 Global Village in Rio offers free access to community programs, while funding cuts to USAID, PEPFAR and other donors raise concerns for HIV services.
8 days ago

[HEALTH] 7 sources
AIDS 2026 Conference in Rio Highlights Funding Cuts and Rising Syphilis Cases
The AIDS 2026 conference in Rio (July 26‑31) gathers 20,000+ experts as AHF spotlights a global syphilis surge, while a >20% drop in international HIV funding threatens community services amid 1.3 million new H

Sources

agorarn.com.br · almasipatika.hu · aredacao.com.br · caririceara.com · correiodecarajas.com.br · destakjornal.com.br · dev.tnonline.com.br · dgabc.com.br · folhabv.com.br · gestos.org.br · imprensapublica.com.br · jornadabc.mx · jornaldebrasilia.com.br · leodias.odia.ig.com.br · newzs.de · ouricuriemfoco.com.br · positivelyaware.com · presseportal.de · revistaviverbrasil.com.br · sportcast.cz · tagesthemen.de · tnonline.com.br · tribunadaserra.com.br · tribunadepetropolis.com.br · truthout.org · valorambiental.com.ar · veja.abril.com.br · vtv.vn

This summary has been updated 2 times: see revision history